Answers are grounded in this paper and cite their sources.
Host blood mRNA signatures hold promise as triage tests for TB. Further optimisation is needed if mRNA signatures are to be used as standalone diagnostic or predictive tests for therapeutic decision-making.
No takes yet. Share an insight, caveat, or question.
Mulenga et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: